CAMP4 Therapeutics Corporation - Common Stock —— 财务报表 (NASDAQ:CAMP) | MetaTrader

展开完整图表完整图表

新闻

CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimates

Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP)

Cantor Fitzgerald reiterates Overweight on CAMP4 stock, $7 target

Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why

Camp4 Therapeutics签署沃特敦新租约，加速退出剑桥

Camp4 Therapeutics signs new Watertown lease, accelerates Cambridge exit

GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst - Camp4 Therapeutics (NASDAQ:CAMP), GSK (NYSE:GSK)

Camp4 Therapeutics股价在定价3000万美元股票发行后下跌

Camp4 Therapeutics stock falls after pricing $30 million share offering

CAMP4 Therapeutics定价3000万美元普通股发行

CAMP4 Therapeutics prices $30 million common stock offering